Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant
Clinical trial NCT00439556 · COMPLETED
Trial details
- NCT number
- NCT00439556
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-13
- Primary completion
- 2018-06-07
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.